- Home 主頁
- About Us 關於我們
- HA公立醫院轉介優惠
- FNA/Biopsy 抽取組織
- Female screening 女士健康篩查
- Health Info 健康資訊
- Contact Us 聯絡我們
- Doctor's Area 醫生專區
- 女士健康篩查Female Screening
A) 乳房及盆腔超聲波
Ultrasound Breasts & Pelvis
B) 2D 乳房X光造影
+ 乳房及盆腔超聲波
2D Mammogram +
Ultrasound Breasts & Pelvis
C) 3D 乳房X光造影
+ 乳房及盆腔超聲波
3D Mammogram
+ Ultrasound Breasts & Pelvis
MRI磁力共振乳癌普查
MRI Breast Cancer Screening
乳房+盆腔+子宮頸檢查套餐
Breast+Pelvis+Pap smear Health Plan
乳房觸診 + 盆腔觸診 + 子宮頸柏氏抹片檢查
Physical examination + Pap Smear
(由女醫生負責檢查 Female doctor)
乳癌普查 (基因)
Breast Cancer Screening DNA
相關遺傳性腫瘤基因檢測 (乳腺、卵巢)
BRCA 1 & 2 + 24 genes
乳癌普查?
Breast Cancer Screening?
乳癌篩檢對患乳癌風險較高的婦女可能有幫助
Breast cancer screening may help women who are in higher risk groups
乳癌普查
Population-based Breast Cancer Screening
過去20年本港乳癌個案上升接近3倍、即每12名女性中便有1人罹患乳癌,有癌症專科醫生建議本港實施全民乳癌普查,估計可以令因患有乳癌的死亡率下降20%至38%。
全民乳癌普查是指通過有系统的方法,向整羣無病徵的特定人口(例如:某個年齡組別),提供乳癌篩檢。到目前為止,仍未肯定全民乳癌普查是否對無病徵的一般婦女利多於弊。因此,你在決定接受乳癌篩檢前應諮詢醫生意見,以了解清楚篩檢的好處和潛在風險。
然而,乳癌篩檢對患乳癌風險較高的婦女可能有幫助。風險因素包括:
帶有某些基因(例如:BRCA1 或 BRCA2)突變;
有家族乳癌或卵巢癌病史;或
有個人的風險因素(例如:在30歲前胸部曾接受放射治療或曾患乳癌);
如你有患乳癌的較高風險因素,應諮詢醫生意見,以了解清楚應否接受乳癌篩檢,應在幾多歲開始做及每次篩檢的相隔時間。
In the past 20 years, the number of breast cancer cases in HK has nearly triple. That is, 1 in 12 women suffers from breast cancer. A cancer specialist previously recommended HK to conduct breast cancer screening, which is estimated to reduct the mortality rate by 20% to 38%.National Breast Cancer Screening refers to a systematic method to provide breast cancer screening to a whole group of specific population without symptoms (for example: a certain age group). So far, it is still unclear whether the breast cancer screening will benefit asymptomatic women. Therefore, you should consult your doctor before decided to undergo breast cancer screening to understand the benefits and potential risks of screening.
However, breast cancer screening is helpful fro women with a higher risk of breast cancer.*Women at high risk are recommended to seek advice from doctors and have mammography screening every year -
carriers of gene mutation linked to breast cancer e.g. BRCA1/2 deleterious mutations;
strong family history of breast or ovarian cancer (e.g. any first-degree female relative is a confirmed carrier of BRCA1/2 deleterious mutations, any first- or second-degree female relative with both breast and ovarian cancer, etc.);
history of radiation therapy to chest for treatment between the age of 10 and 30
previous history of invasive or in situ breast cancer; invasive lobular carcinoma; atypical ductal hyperplasia or atypical lobular hyperplasia.
*Women at moderate risk are recommended to have mammography screening every two years and should discuss with their doctors the potential benefits and harms of breast cancer screening -
family history of only one first-degree female relative with breast cancer diagnosed at or before the age of 50 or
two first-degree female relatives diagnosed with breast cancer after the age of 50.
Click here for: